Trial intelligence / Profile preview

Lidocaine versus dexamethasone for prevention of fentanyl-induced cough during anesthesia induction in children

IRCT20160301026866N10Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of lidocaine, dexamethasone and fentanyl in cough (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Incidence of fentanyl-induced cough and Severity of fentanyl-induced cough. Started Oct 2018; status: completed.

02

Drugs

lidocainedexamethasonefentanyl
03

Conditions

cough

Beyond the preview

Go deeper on IRCT20160301026866N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160301026866N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call